WO2011116491A1 - Preparation method for nortropine benzilate and its salts and intermediates used in said method - Google Patents
Preparation method for nortropine benzilate and its salts and intermediates used in said method Download PDFInfo
- Publication number
- WO2011116491A1 WO2011116491A1 PCT/CN2010/000347 CN2010000347W WO2011116491A1 WO 2011116491 A1 WO2011116491 A1 WO 2011116491A1 CN 2010000347 W CN2010000347 W CN 2010000347W WO 2011116491 A1 WO2011116491 A1 WO 2011116491A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- acid
- reaction
- ester
- compound
- Prior art date
Links
- HIIVXBCWDPCZJA-UHFFFAOYSA-N OC(C(OC1CC(CC2)NC2C1)=O)(c1ccccc1)c1ccccc1 Chemical compound OC(C(OC1CC(CC2)NC2C1)=O)(c1ccccc1)c1ccccc1 HIIVXBCWDPCZJA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
Definitions
- This invention relates to a novel process for the preparation of decanoic acid esters of diphenylglycolic acid and salts thereof, and to novel intermediates for use in the process.
- This method is characterized by the removal of cbz by hydrogenation with Pd-C to achieve the purpose of dethiolation, and the acid chloride used for esterification is prepared by using PC1 5 .
- the disadvantage is that the reagents used (PC1 5 , pyridine) cause serious pollution to the environment, and the Alpha chlorine is hydrolyzed into a hydroxyl group in the process, which is extremely inconvenient to operate, high in cost, and difficult to purify the product.
- Xu Rongsen et al. (CN 101003535A, 2007-07-25) discloses an improved method with a high yield and a total yield of about 60%.
- This method starts from a top product, is esterified with a-hydroxy-CC-phenylphenylacetate, and is deaminated with ethyl chlororuthenate and HBr/HAc to obtain a deuterated ester of diphenylglycolic acid.
- the reaction conditions of the method are too severe, it is difficult to control the tropine ester to be not destroyed, and the intermediate bromide is still subjected to the hydrolysis step to obtain the product, which is complicated in operation and difficult to control, and is not suitable for industrial production.
- One of the objects of the present invention is to provide a novel method for preparing a diphenylglycolic acid deuterated ester of the following formula (1) and a salt thereof.
- the method has the characteristics of mild reaction condition, simple operation, short reaction time, high yield, less environmental pollution, easy control of finished product quality, and is suitable for industrial production.
- a second object of the present invention is to provide a novel intermediate for the preparation of the diphenylglycolic acid deuterated ester of the formula (1) and a salt thereof, and a process for the preparation of the intermediate.
- the method of the invention comprises the following steps:
- R represents dC 4 alkyl, halo d-C 4 alkyl or phenyl
- Hal represents hydrogen, chlorine or bromine
- the benzoate of the formula (4) is prepared according to the method described by R. Banholzer et al. (Arzneim. - Forsch, 36 (II), 8, 1161-1166, 1986); Further reacting with chlorophthalic acid ester at 0-100 ° C to obtain an intermediate of formula (5), separating the intermediate and then performing hydrolysis or alcoholysis reaction, or directly purifying the intermediate, directly proceeding to the next step
- the hydrolysis or alcoholysis reaction gives the diphenyl alcohol acetate deuterated ester of the formula (1); then, the compound of the formula (1) is optionally reacted with an acid to obtain a salt thereof.
- the reaction process is as follows:
- the transesterification of the oxime of the formula (2) and the diphenyl hydroxyacetimidazole of the formula (3) for the transesterification of the benzoic acid ester of the formula (4) in a common inert solvent preferably an inert solvent From acetone, mercaptoethyl ketone, butanone, tetrahydrofuran, dichloroethane, benzene, toluene, dinonylbenzene, and mixtures thereof. More preferred inert solvents are acetone, butanone, tetrahydrofuran, benzene, and mixtures thereof.
- the reaction temperature is from room temperature to 11 CTC, preferably from room temperature to 80 °C, more preferably from room temperature to 60 °C.
- the reaction is from 30 minutes to 10 hours, preferably from 2 to 6 hours.
- the reaction of the compound of the formula (4) with chlorodecanoate to prepare a compound of the formula (5) is also carried out in an inert solvent.
- the inert solvent is selected from the group consisting of chloroform, dichloro-decane, 1,2-dichloroethane, benzene, toluene, diphenylbenzene, and mixtures thereof.
- the preferred solvents are chloroform, dichlorodecane, 1,2-dichloroethane and mixtures thereof.
- reaction temperature is 0-110 ° C, and the preferred reaction temperature is room temperature to 60 ° C.
- Reaction time is 4 to 20 hours, preferably 10 to 15 hours.
- the chlorophthalic acid ester used in the reaction is selected from the group consisting of: benzyl chlorate, ethyl chlorohydrazide, 1-chloroethyl chloroantimonate, 1-bromoethyl chloroantimonate, propyl chloroformate, chloroformic acid 1 -chloropropyl ester, 1-bromopropyl chloroantimonate, butyl chloroantimonate, 1-chlorobutyl chlorate, 1-bromobutyl chlorate, 2, 2, 2-trichloroethane Esters and mixtures thereof.
- the chlorophthalic acid ester is used in the reaction in an amount of usually 1 to 10 equivalents, preferably 1 to 5 equivalents to the compound of the formula (4).
- the above reaction produces an alkoxy or substituted alkoxycarbonyl deuterated intermediate of the formula (5), which is directly subjected to hydrolysis or alcoholysis without isolation to obtain a formula (1). ) compound.
- the hydrolysis reaction is a conventional acid hydrolysis reaction, and the acid used is a usual organic or inorganic acid, preferably hydrochloric acid, sulfuric acid, acetic acid, glacial acetic acid and a mixture thereof. More preferred are concentrated hydrochloric acid, aqueous acetic acid and mixtures thereof.
- the reaction temperature is 10-10 (TC, preferably room temperature to 7 (TC; the reaction time is 5-20 hours, preferably 8-12 hours).
- the alcoholysis reaction is a conventional alcoholysis reaction condition.
- Preferred solvents are decyl alcohol, ethanol, or mixtures thereof or mixtures thereof with water.
- the reaction temperature is from 10 to 85 ° C, preferably from room temperature to 60 ° C; and the reaction time is from 0.5 to 8 hours, preferably from 1 to 4 hours.
- Salts of the compounds of formula (1) include pharmaceutically acceptable salts with organic or inorganic acids.
- the inorganic acid include hydrochloric acid, sulfuric acid, hydrobromic acid, hydroiodic acid, phosphoric acid and the like.
- the organic acid include acetic acid, citric acid, citric acid, tartaric acid, ascorbic acid and the like.
- the method of the present invention disclosed above has mild reaction conditions, short reaction time, short reaction process, high operation rate, high yield, and easy purification of the finished product.
- the desulfurization reaction is extremely mild, the yield is high, the cost is low, and the environment is non-polluting, which is very suitable for industrialized large-scale production.
- Another aspect of the invention also provides a novel intermediate of the following formula (5)
- R represents a dC alkyl group, a halogenated d_C 4 alkyl group or a phenyl group
- Ha l represents hydrogen, chlorine or bromine.
- a particularly preferred compound of the formula (5) is a compound wherein R represents a methyl group and Ha l represents hydrogen or chlorine.
- the glycyl imidazole 38. 9 g (0.24 mol) was dissolved in 130 ml of dichloromethane, and the phenylglycolic acid was added in portions, 54. 8 g (0.24 mol), at 15-20. C was stirred and mixed, and after precipitation, the reaction was continued for 2-5 hours. Filtration, washing with dichloromethane (30 ml X 2 ), drying to give diphenylcarbamic acid imide 52 g (94.5%), mp 38-139 ° C (dec), recrystallized from acetone, mp 47-148 ° C.
- the pharmaceutically acceptable product of formula (2) 14. lg (0.1 mol) was dissolved in acetone 60 ml, and diphenyl hydroxyacetimidazole (compound of formula 3) 27. 8 g (0.1 mol) was added in portions, as described above. In the solution. After the product was precipitated, the mixture was refluxed for 5 h, cooled to 0 ° C, filtered, washed with acetone, and then dried to give the title compound (3) of benzene benzoate (31.73 g) (yield 90.0%).
- the intermediate 11.9 kg, concentrated hydrochloric acid 100 kg, and acetic acid acetic acid 62.4 kg were put into a 300 L reaction kettle, stirred, heated at 95-100 ° C for 14 h, and the reaction solution was concentrated to dryness; chloroform 88.6 kg, water was added to the residue. 47.6 kg.
- the mixture was alkalized with aqueous sodium hydroxide solution with thorough stirring, stirred for 30 minutes, and allowed to stand for stratification.
- the lower layer was washed with 30 kg of water, and concentrated to dryness to obtain diphenyl glycolic acid to remove the ester (1) 6.25 kg, yield 50%.
- the content of HPLC was determined to be 99.2%;
- benzoic acid tropine ester (compound of formula 4) 35. lg (0. lmol) is dissolved in 350 ml of 1,2-dichloroethane, and benzyl chloride chlorate (25.65 g (0.15 mol) is added under (TC) The reaction mixture was stirred at room temperature overnight, until the reaction was completed by TLC, and the solvent was evaporated under reduced pressure to give the crude product of N-(benzyloxycarbonyl) dehydrazide intermediate.
- Example 2b (1) The decanoic acid ester of diphenylglycolate obtained in Example 2b (1) is treated with a solution of hydrogen chloride or a solution of guanidinium chloride to obtain a hydrochloride salt of decanoic acid (formula 1).
- the filtrate is stirred and cooled to precipitate solid. It is cooled to room temperature at about 20 °C for 4h, then reduced to 5 °C, suction filtered, with 0-5 °C. After washing with ethanol, after drying, it was dried at 50 ° C to obtain 42.6 kg of diphenyl glycolic acid dehydrobenzoate hydrochloride, and the yield was 80%.
- diphenyl glycolate (4) 35. lg (0. lmol) is dissolved in 400 ml of 1,2-dichloroethane, and chloric acid-2, 2, 2-3 is added at 0 °C. Chloroethyl ester 27.5 ml (about 42.4 g, 0.2 mol, 2 eq.).
- Ethanol was evaporated under reduced pressure, and the residue was dissolved in 80 ml of tert-butyl oxime ether, filtered to remove insolubles, and the solvent was evaporated to give diphenylglycolic acid.
- the ester was 38.38 g, and the yield was 89%.
- the solution was treated with a hydrochloric acid/ethanol solution to obtain a diphenyl glycolic acid dehydrobenzoate ester.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE112010005112T DE112010005112T5 (en) | 2010-03-22 | 2010-03-22 | Process for the preparation of Nortropylbenzilat and its salts and intermediates used in the process |
PCT/CN2010/000347 WO2011116491A1 (en) | 2010-03-22 | 2010-03-22 | Preparation method for nortropine benzilate and its salts and intermediates used in said method |
CN2010800095410A CN102333775A (en) | 2010-03-22 | 2010-03-22 | Preparation method for nortropine benzilate and its salts and intermediates used in said method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2010/000347 WO2011116491A1 (en) | 2010-03-22 | 2010-03-22 | Preparation method for nortropine benzilate and its salts and intermediates used in said method |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011116491A1 true WO2011116491A1 (en) | 2011-09-29 |
Family
ID=44672421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2010/000347 WO2011116491A1 (en) | 2010-03-22 | 2010-03-22 | Preparation method for nortropine benzilate and its salts and intermediates used in said method |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN102333775A (en) |
DE (1) | DE112010005112T5 (en) |
WO (1) | WO2011116491A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102718760A (en) * | 2012-06-01 | 2012-10-10 | 寿光富康制药有限公司 | Trospium chloride synthesis process |
CN102964345A (en) * | 2012-12-06 | 2013-03-13 | 四川理工学院 | Method for preparing 2-hydroxy-2,2-diphenylacetic acid-3alpha-(8-aza-bicyclo(3,2,1))-3-trioctyl |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080027094A1 (en) * | 2004-08-30 | 2008-01-31 | Ono Pharmaceutical Co., Ltd. | Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient |
CN101643472A (en) * | 2008-08-07 | 2010-02-10 | 北京迈劲医药科技有限公司 | Method for preparing 2-hydroxyl-2,2-diphenyl acetic acid-3alpha-(8-azabicyclo[3,2,1]-3-octyl ester |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2487340A1 (en) * | 1980-07-24 | 1982-01-29 | Poudres & Explosifs Ste Nale | NOVEL PROCESS FOR THE DEALKYLATION OF TERTIARY AMINES BY USE OF A-CHLORINE CHLOROFORMIATES |
JP3829879B2 (en) * | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | Quinoline carboxylic acid derivatives |
US6567791B2 (en) * | 1998-11-03 | 2003-05-20 | Nextcard, Inc. | Method and apparatus for a verifiable on line rejection of an application for credit |
CN101003535A (en) | 2006-01-17 | 2007-07-25 | 上海绿健医药技术有限公司 | Alpha hydroxy - alpha phenyl phenylacetic acid 8 - aza dicyclo [3. 2. 1] - 3 heptyl ester, midbody compound, and preparation method |
-
2010
- 2010-03-22 DE DE112010005112T patent/DE112010005112T5/en not_active Withdrawn
- 2010-03-22 WO PCT/CN2010/000347 patent/WO2011116491A1/en active Application Filing
- 2010-03-22 CN CN2010800095410A patent/CN102333775A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080027094A1 (en) * | 2004-08-30 | 2008-01-31 | Ono Pharmaceutical Co., Ltd. | Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient |
CN101643472A (en) * | 2008-08-07 | 2010-02-10 | 北京迈劲医药科技有限公司 | Method for preparing 2-hydroxyl-2,2-diphenyl acetic acid-3alpha-(8-azabicyclo[3,2,1]-3-octyl ester |
Non-Patent Citations (1)
Title |
---|
A. B. KOSMACHEV ET AL.: "Synthesis and study of the selectivity of the M-choline eceptor blocking activity of norglipin", KHIMIKO-FARMATSEVTICHESKII ZHURNAL, vol. 32, no. 6, 1998, pages 15 - 17 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102718760A (en) * | 2012-06-01 | 2012-10-10 | 寿光富康制药有限公司 | Trospium chloride synthesis process |
CN102718760B (en) * | 2012-06-01 | 2014-07-02 | 寿光富康制药有限公司 | Trospium chloride synthesis process |
CN102964345A (en) * | 2012-12-06 | 2013-03-13 | 四川理工学院 | Method for preparing 2-hydroxy-2,2-diphenylacetic acid-3alpha-(8-aza-bicyclo(3,2,1))-3-trioctyl |
Also Published As
Publication number | Publication date |
---|---|
DE112010005112T5 (en) | 2012-12-06 |
CN102333775A (en) | 2012-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013049605A1 (en) | Processes for the preparation of an intermediate in the synthesis of eltrombopag | |
JP4048119B2 (en) | Process for producing 2- (4-chlorobenzoylamino) -3- [2 (1H) -quinollinon-4-yl] propionic acid | |
JPS61251650A (en) | Manufacture of (z)-1-phenyl-1-diethylaminocarbonyl-2- aminomethylcyclopropanehydrochloride | |
WO2010140168A1 (en) | Improved process for preparing temozolomide | |
EP2471795B1 (en) | Method for preparing prasugrel | |
CN113121416A (en) | Preparation method of lefenacin | |
JP4330836B2 (en) | Process for producing piperazine derivatives | |
JP3440129B2 (en) | Method for producing glutamine derivative | |
WO2011116491A1 (en) | Preparation method for nortropine benzilate and its salts and intermediates used in said method | |
TW201802103A (en) | Preparation method of obeticholic acid and intermediates thereof | |
KR101427221B1 (en) | Proces for purifying fluvoxamine free base and process for preparing high purity fluvoxamine maleate using the same | |
CA2420847C (en) | Process for producing erythromycin derivative | |
WO2008096373A2 (en) | Process for synthesizing highly pure nateglinide polymorphs | |
KR20030050412A (en) | A process for preparing rebamipide | |
CN113620869B (en) | Preparation method of betrixaban | |
EP0481118A1 (en) | A method for producing butyl 3'-(1H-tetrazol-5-yl) oxanilate | |
JP2020070296A (en) | Method for producing linagliptin | |
JP3907787B2 (en) | Method for producing benzoic acid derivative | |
CN111247127B (en) | Process for the production of intermediate compounds for the synthesis of medicaments | |
CA2778807A1 (en) | Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone | |
EP3722285B1 (en) | Process for preparing mirabegron enacarbil | |
CA2487672C (en) | Industrial process for preparing tropenol | |
JPH0446175A (en) | Production of 5-hydroxy-3,4-methylenedioxybenzoic acid derivative | |
CN116836141A (en) | New bevacizidine intermediate, preparation method thereof and method for synthesizing bevacizidine by using same | |
CN116715663A (en) | Preparation method of non-neridrone and intermediate thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080009541.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10848153 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2907/DELNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 112010005112 Country of ref document: DE Ref document number: 1120100051127 Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10848153 Country of ref document: EP Kind code of ref document: A1 |